Full name
MECCONTI S.A.R.L. SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.75.Z - Wholesale trade
20.59.Z - Manufacture of other chemical products, not elsewhere classified
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.69.Z - Wholesale trade
46.90.Z - Non-specialized wholesale trade
47.91.Z - Intermediary retail sale, non-specialized
47.99.Z - Retail trade
71.20 - Technical testing and analysis
72.1 - Scientific research and development in natural and technical sciences
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,2 | 0 | -0,3 | -1281,9 |
Gross profit (loss) | 0,6 | 1,5 | -0,1 | -107,8 |
EBITDA | 0,6 | 1,7 | 0,5 | -73,4 |
Short time liabilities | 0,5 | 1 | 0,4 | -56,7 |
Other operating costs | 1,3 | 0 | 0,8 | -∞ |
Income tax | 69,5 | |||
Equity capital | 4,9 | 6,3 | 6,2 | -2,2 |
Operating profit (EBIT) | 0,6 | 1,5 | -0,1 | -108,6 |
Assets | 7,4 | 9,7 | 9 | -7,1 |
Net profit (loss) | 0,5 | 1,5 | -0,1 | -109,6 |
Cash | 1,7 | 2,1 | 1,9 | -9,2 |
Net income from sale | 3 | 3,7 | 3,6 | -3,2 |
Liabilities and provisions for liabilities | 2,5 | 3,4 | 2,9 | -16 |
Working assets | 3,7 | 3,7 | 3,4 | -6,4 |
Other income costs | 1,7 | 1,5 | 1 | -36,4 |
Depreciation | 0 | 0,2 | 0,6 | 169,8 |
Basic operational activity income | 26,7 | |||
% | % | % | p.p. | |
Profitability of capital | 11,3 | 23 | -2,3 | -25,3 |
Equity capital to total assets | 65,9 | 65 | 68,4 | 3,4 |
Gross profit margin | 19 | 39,3 | -3,2 | -42,5 |
EBITDA Margin | 18,8 | 46,7 | 12,8 | -33,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 56 | 94 | 42 | -52 |
Current financial liquidity indicator | 8.076761245727539 | 3.8279101848602295 | 8.267473220825195 | 4,5 |
Net dept to EBITDA | 0.5762888789176941 | 0.1890188306570053 | 1.1283100843429565 | 0,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane